2019 Q2 Form 10-Q Financial Statement

#000143774919016237 Filed on August 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $6.701M $5.178M
YoY Change 29.41% 102.44%
Cost Of Revenue $1.968M $1.537M
YoY Change 28.04% 60.63%
Gross Profit $4.743M $3.641M
YoY Change 30.27% 127.43%
Gross Profit Margin 70.78% 70.32%
Selling, General & Admin $3.152M $2.031M
YoY Change 55.19% 25.1%
% of Gross Profit 66.46% 55.78%
Research & Development $691.0K $325.0K
YoY Change 112.62% 2.01%
% of Gross Profit 14.57% 8.93%
Depreciation & Amortization $110.0K $80.00K
YoY Change 37.5% -11.11%
% of Gross Profit 2.32% 2.2%
Operating Expenses $5.954M $3.893M
YoY Change 52.94% 100.45%
Operating Profit $747.0K $1.285M
YoY Change -41.87% -476.61%
Interest Expense $1.000K $1.000K
YoY Change 0.0% -99.04%
% of Operating Profit 0.13% 0.08%
Other Income/Expense, Net $3.505M -$27.63M
YoY Change -112.69% 6370.82%
Pretax Income $4.252M $1.139M
YoY Change 273.31% -248.27%
Income Tax
% Of Pretax Income
Net Earnings $4.252M -$26.35M
YoY Change -116.14% 3329.52%
Net Earnings / Revenue 63.45% -508.81%
Basic Earnings Per Share $0.18 -$1.74
Diluted Earnings Per Share $0.02 -$1.74
COMMON SHARES
Basic Shares Outstanding 18.82M 15.18M
Diluted Shares Outstanding 24.54M 15.18M

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.60M $100.0K
YoY Change 19500.0% -95.65%
Cash & Equivalents $19.62M $14.17M
Short-Term Investments $100.0K
Other Short-Term Assets $400.0K $14.50M
YoY Change -97.24% 3525.0%
Inventory $5.306M $2.122M
Prepaid Expenses
Receivables $3.832M $2.166M
Other Receivables $0.00 $0.00
Total Short-Term Assets $29.14M $18.81M
YoY Change 54.94% 231.16%
LONG-TERM ASSETS
Property, Plant & Equipment $1.318M $1.044M
YoY Change 26.25% -11.59%
Goodwill $9.515M
YoY Change
Intangibles $4.016M
YoY Change
Long-Term Investments $6.100M $1.900M
YoY Change 221.05% 18.75%
Other Assets $100.0K $0.00
YoY Change
Total Long-Term Assets $22.16M $2.980M
YoY Change 643.76% 6.33%
TOTAL ASSETS
Total Short-Term Assets $29.14M $18.81M
Total Long-Term Assets $22.16M $2.980M
Total Assets $51.30M $21.79M
YoY Change 135.48% 156.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $876.0K $843.0K
YoY Change 3.91% 58.48%
Accrued Expenses $204.0K $173.0K
YoY Change 17.92% 171.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $3.163M $1.664M
YoY Change 90.08% 59.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.000K $45.00K
YoY Change -84.44% -19.84%
Total Long-Term Liabilities $7.000K $45.00K
YoY Change -84.44% -19.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.163M $1.664M
Total Long-Term Liabilities $7.000K $45.00K
Total Liabilities $49.23M $34.73M
YoY Change 41.75% 1991.27%
SHAREHOLDERS EQUITY
Retained Earnings -$113.3M -$94.72M
YoY Change 19.62%
Common Stock $115.4M $81.78M
YoY Change 41.08% 2.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.072M -$12.94M
YoY Change
Total Liabilities & Shareholders Equity $51.30M $21.79M
YoY Change 135.48% 156.87%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $4.252M -$26.35M
YoY Change -116.14% 3329.52%
Depreciation, Depletion And Amortization $110.0K $80.00K
YoY Change 37.5% -11.11%
Cash From Operating Activities -$70.00K $560.0K
YoY Change -112.5% -660.0%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K -$20.00K
YoY Change 450.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities -$12.44M -$1.000M
YoY Change 1144.0%
Cash From Investing Activities -$12.55M -$1.020M
YoY Change 1130.39% 2450.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 410.0K 7.590M
YoY Change -94.6% 4364.71%
NET CHANGE
Cash From Operating Activities -70.00K 560.0K
Cash From Investing Activities -12.55M -1.020M
Cash From Financing Activities 410.0K 7.590M
Net Change In Cash -12.21M 7.130M
YoY Change -271.25% 23666.67%
FREE CASH FLOW
Cash From Operating Activities -$70.00K $560.0K
Capital Expenditures -$110.0K -$20.00K
Free Cash Flow $40.00K $580.0K
YoY Change -93.1% -1066.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
0
CY2018Q2 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
32000
blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
63000
CY2019Q2 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
0
blfs Amortization Of Operating Lease Liability
AmortizationOfOperatingLeaseLiability
87000
blfs Amortization Of Operating Lease Liability
AmortizationOfOperatingLeaseLiability
CY2019Q2 blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
24000
blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
29000
CY2019Q2 blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
blfs Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
blfs Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-6000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Accumulated Amortization
LandlordfundedLeaseholdImprovementsAccumulatedAmortization
757000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Gross
LandlordfundedLeaseholdImprovementsGross
1125000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Net
LandlordfundedLeaseholdImprovementsNet
368000
blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
8000
blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
5000
blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
601000
blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
8899000
blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
150000
CY2018Q4 blfs Straightline Rent Adjustment
StraightlineRentAdjustment
111000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000834365
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19002764
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
BIOLIFE SOLUTIONS INC
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
blfs
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
876000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
720000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3832000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3045000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
204000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
91000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2276000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2328000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
116013000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114160000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1252000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
646000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
748000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
374000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
646000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
374000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1252000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
748000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
CY2019Q2 us-gaap Assets
Assets
51742000
CY2018Q4 us-gaap Assets
Assets
45467000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
29139000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
37564000
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
39000
CY2018Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
247000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
CY2019Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
371000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
CY2019Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1560000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30657000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19617000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14166000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11040000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7503000
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.34
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.35
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4048505
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4080005
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18898609
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18547406
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18898609
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18547406
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
19000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1958000
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1537000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3606000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk and business risk</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer and in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer. In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38%</div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers and in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customer accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of revenue in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">82%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87%,</div> of our revenue from CryoStor products, respectively. In each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86%,</div> of our revenue from CryoStor products. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28%</div> of total gross accounts receivable. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71%</div> of total gross accounts receivable.&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Revenue from customers located in Canada represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div> and in all other foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%</div> of total revenue during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019, </div>respectively. Revenue from customers located in Canada represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> and in all other foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total revenue during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>respectively. All revenue from foreign customers is denominated in United States dollars.</div></div></div></div></div>
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2901000
CY2018Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
479000
CY2019Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130000
CY2019Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
349000
CY2019Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
136000
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36000
us-gaap Depreciation
Depreciation
209000
us-gaap Depreciation
Depreciation
161000
CY2019Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2018Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
93000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
200000
CY2018Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
93000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
963000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
998000
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
6100000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6548000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
CY2019Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
23000
CY2019Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
14000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
CY2019Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
25000
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
3000
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
15000
CY2019Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
7000
CY2019Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2000
CY2019Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.081
CY2019Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y255D
CY2019Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
577000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
706000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2118000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1390000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4321000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2744000
CY2019Q2 us-gaap Goodwill
Goodwill
9524000
CY2018Q4 us-gaap Goodwill
Goodwill
CY2019Q2 us-gaap Gross Profit
GrossProfit
4743000
CY2018Q2 us-gaap Gross Profit
GrossProfit
3641000
us-gaap Gross Profit
GrossProfit
8865000
us-gaap Gross Profit
GrossProfit
6092000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
838000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1139000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1265000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1143000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-448000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-321000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-217000
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-177000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-36000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
168000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
632000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1145000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1341000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
275000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-53000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
103000
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4446000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
CY2019Q2 us-gaap Interest Expense
InterestExpense
1000
CY2018Q2 us-gaap Interest Expense
InterestExpense
1000
us-gaap Interest Expense
InterestExpense
4000
us-gaap Interest Expense
InterestExpense
1000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2963000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1404000
CY2019Q2 us-gaap Inventory Net
InventoryNet
5306000
CY2018Q4 us-gaap Inventory Net
InventoryNet
3509000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2068000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1453000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
275000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
652000
CY2019Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1578000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
452000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
764000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
362000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
107000
CY2019Q2 us-gaap Liabilities
Liabilities
5476000
CY2018Q4 us-gaap Liabilities
Liabilities
2319000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51742000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45467000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3093000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1939000
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2019Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2019Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1733000
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1657000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
586000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7611000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12705000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1061000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1079000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
953000
us-gaap Net Income Loss
NetIncomeLoss
1265000
us-gaap Net Income Loss
NetIncomeLoss
1143000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
838000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
1139000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
838000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1046000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1265000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
943000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-145000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-281000
us-gaap Notes Issued1
NotesIssued1
us-gaap Notes Issued1
NotesIssued1
18000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
3824000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
2356000
us-gaap Operating Expenses
OperatingExpenses
7455000
us-gaap Operating Expenses
OperatingExpenses
4668000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
919000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1285000
us-gaap Operating Income Loss
OperatingIncomeLoss
1410000
us-gaap Operating Income Loss
OperatingIncomeLoss
1424000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
142000
us-gaap Operating Lease Cost
OperatingLeaseCost
285000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1800000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1471000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
665000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
806000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
186000
us-gaap Operating Lease Payments
OperatingLeasePayments
371000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1300000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1079000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2019Q2 us-gaap Other Income
OtherIncome
137000
CY2018Q2 us-gaap Other Income
OtherIncome
32000
us-gaap Other Income
OtherIncome
307000
us-gaap Other Income
OtherIncome
41000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
1063000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
213000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12438000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
267000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61000
CY2019Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2018Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
93000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
200000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
384000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
353000
CY2019Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
114000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
138000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3594000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3647000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1318000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1319000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
7000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
7000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
739000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
325000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1111000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
671000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69766000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71031000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6701000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5178000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12471000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8993000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
928000
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
641000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1776000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1253000
us-gaap Share Based Compensation
ShareBasedCompensation
1252000
us-gaap Share Based Compensation
ShareBasedCompensation
748000
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued1
StockIssued1
36000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
601000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
416000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8899000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8827000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1063000
CY2018Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1063000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
43148000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
46266000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
44366000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
10092000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
19655000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
10471000
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5719840
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5194189
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5705558
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4421217
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24539299
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20374358
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24439959
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19063595
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18819459
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15180169
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18734401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14642378

Files In Submission

Name View Source Status
0001437749-19-016237-index-headers.html Edgar Link pending
0001437749-19-016237-index.html Edgar Link pending
0001437749-19-016237.txt Edgar Link pending
0001437749-19-016237-xbrl.zip Edgar Link pending
bioli20190630_10q.htm Edgar Link pending
bioli20190630_10qimg001.gif Edgar Link pending
blfs-20190630.xml Edgar Link completed
blfs-20190630.xsd Edgar Link pending
blfs-20190630_cal.xml Edgar Link unprocessable
blfs-20190630_def.xml Edgar Link unprocessable
blfs-20190630_lab.xml Edgar Link unprocessable
blfs-20190630_pre.xml Edgar Link unprocessable
ex_152663.htm Edgar Link pending
ex_152664.htm Edgar Link pending
ex_152665.htm Edgar Link pending
ex_152666.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending